Nextcure to present at 22nd annual needham virtual healthcare conference

Beltsville, md., april 11, 2023 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the 22nd annual needham virtual healthcare conference on wednesday, april 19th, at 10:15 am et.
NXTC Ratings Summary
NXTC Quant Ranking